AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUL 1 - (NewsRx.com & NewsRx.net) -- iCAD, Inc., (ICAD), which designs, develops, and markets computer-aided detection (CAD) imaging technology and systems for the early detection of breast cancer and other medical applications, announced approval from the U.S. Food and Drug Administration for release of iCAD's new Second Look 200 system for early detection of breast cancer.
The Second Look 200 is specifically designed to make CAD accessible to smaller breast-care centers.
According to the company, it can analyze up ...
Source: HighBeam Research, FDA approves Second Look 200 for breast-cancer detection.